Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • In Brief
  • Published:

Multiple sclerosis

Brain volume loss strengthens disease measure

Nature Reviews Neurology volume 12, page 2 (2016)Cite this article

Subjects

Access through your institution
Buy or subscribe

Including brain volume loss as an additional criterion in the 'no evidence of disease activity' (NEDA) measure of relapsing–remitting multiple sclerosis progression could help to assess neurodegeneration as well as inflammation. NEDA-3, the current form of the measure, is defined as the absence of disease activity on MRI, relapses and the progression of disability. Ludwig Kappos et al. updated the measure to NEDA-4 by adding brain volume loss, and applied it to analyse pooled data from two trials of fingolimod. NEDA-4 reduced the proportion of participants who achieved NEDA, but remained sensitive to the benefits of treatment detected with NEDA-3.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kappos, L. et al. Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing–remitting multiple sclerosis. Mult. Scler. http://dx.doi.org/10.1177/1352458515616701

Download references

Authors
  1. Ian Fyfe
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fyfe, I. Brain volume loss strengthens disease measure. Nat Rev Neurol 12, 2 (2016). https://doi.org/10.1038/nrneurol.2015.245

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrneurol.2015.245

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing